|
|
|
|
|
|
Companies > Commercial
|
|
|
Synapse has developed the FDA approved NeuRx Diaphragm Pacing System™, a neurostimulation technology designed to help spinal cord injury and ALS patients decrease their dependency on mechanical ventilation. The technology is also being developed for diaphragm conditioning in respiratory short-term intensive care setting.
Funders:
Vivo Ventures, Palo Alto Investors, Case Technology Ventures, JumpStart
|
|
|
|
|